Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. cephalosporins active against MRSA, MRCNS

Nov. 25, 1996

Lilly claims structurally novel NK1 antagonists

Nov. 25, 1996

Mercian discloses novel mitomycin

Nov. 22, 1996

Japanese researchers disclose anti-HIV agents

Nov. 22, 1996

Antitumor lactam isolated by Japanese researchers

Nov. 22, 1996

New carbapenems from Takeda

Nov. 22, 1996

Otsuka describes novel cephems

Nov. 22, 1996

Antidiabetic agents reported by Terumo

Nov. 22, 1996

Antithrombotic/antiallergic agents from Terumo

Nov. 22, 1996

Otsuka discloses inhibitor of TNF-alpha production

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...